Duo Oncology
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Duo Oncology is currently valued at N/A as of July 11, 2025. The company has raised a total of $13.1M in funding.
Investment Perspective
Duo Oncology's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Duo Oncology Worth in 2025?
As of 2025, Duo Oncology is valued at N/A, based on the company's Later Stage VC funding round in July 11, 2025. This valuation positions Duo Oncology as one of the leading private companies in the sector.
Duo Oncology Valuation History
Duo Oncology's funding history demonstrates steady growth and investor confidence.
How Duo Oncology Valuation is Determined
Private company valuations like Duo Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Duo Oncology Valuation FAQs
Is Duo Oncology profitable?
Duo Oncology has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Duo Oncology's valuation compare to competitors?
Duo Oncology is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Duo Oncology IPO?
Duo Oncology has not announced plans for an initial public offering. Until an IPO, investors can access Duo Oncology shares through secondary market platforms.